Julie Gueudry

9PUBLICATIONS
9CO-AUTHORS
Social epidemiologyMedical mycologyAllergyOptical technologyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors.

|May 27, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoid.

|Oct 28, 2025
Janus kinase inhibitors are effective in atopic keratoconjunctivitis treatment and not only in managing dupilumab-induced ocular adverse events.

Yasmine Bendoukha, Benjamin Jacob, Marc Muraine

|Apr 18, 2025
Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study.

Maxime Quirke, Fabien Lamoureux, Christophe Arnoult

|Jan 20, 2025
Selective Tissue Penetration of the Corneal Layers of Cyclosporin 2% Associated with Miglyol in Rabbits.

Gladys Gress, Fabien Lamoureux, Julien Bourgain

|May 20, 2024
Promising response to Wharton's jelly eye drops in severe ocular involvement during acute phase of epidermal necrolysis and erythema multiforme major.

Julie Gueudry, Manel Narimane Terkmane, Florence Tétart

Pageof 2